You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for LEVOCARNITINE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for LEVOCARNITINE

Average Pharmacy Cost for LEVOCARNITINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
LEVOCARNITINE 330 MG TABLET 16571-0762-09 0.68958 EACH 2024-12-18
LEVOCARNITINE 330 MG TABLET 70954-0492-10 0.68958 EACH 2024-12-18
LEVOCARNITINE 1 G/10 ML SOLN 70954-0139-10 0.13739 ML 2024-12-18
LEVOCARNITINE SF 1 G/10 ML SOL 70954-0140-10 0.22424 ML 2024-12-18
LEVOCARNITINE 1 G/10 ML SOLN 52817-0830-04 0.13739 ML 2024-12-18
LEVOCARNITINE 1 G/10 ML SOLN 64980-0503-12 0.13739 ML 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for LEVOCARNITINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
LEVOCARNITINE 330MG TAB Golden State Medical Supply, Inc. 70954-0492-10 90 57.17 0.63522 EACH 2023-12-15 - 2028-06-14 FSS
CARNITOR 330MG TAB Leadiant Biosciences, Inc. 54482-0144-07 90 55.62 0.61800 EACH 2022-01-01 - 2026-08-31 FSS
CARNITOR SUGAR FREE ORAL SOLUTION 4OZ Leadiant Biosciences, Inc. 54482-0148-01 118ML 30.84 0.26136 ML 2023-01-01 - 2026-08-31 FSS
CARNITOR 1GM/5ML INJ VIAL Leadiant Biosciences, Inc. 54482-0147-01 5X5ML 65.93 2021-09-01 - 2026-08-31 FSS
CARNITOR 330MG TAB Leadiant Biosciences, Inc. 54482-0144-07 90 60.18 0.66867 EACH 2023-01-01 - 2026-08-31 FSS
CARNITOR SUGAR FREE ORAL SOLUTION 4OZ Leadiant Biosciences, Inc. 54482-0148-01 118ML 30.76 0.26068 ML 2024-01-01 - 2026-08-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

LEVOCARNITINE Market Analysis and Financial Projection

Levocarnitine Market Analysis and Price Projections

Executive Summary

The levocarnitine market, also known as L-carnitine, is poised for significant growth driven by increasing consumer awareness of health and fitness, along with its diverse applications in healthcare and animal nutrition. Here is a comprehensive analysis of the market dynamics, segmentation, and price projections.

Market Size and Growth Projections

The global levocarnitine market is expected to witness substantial growth over the next decade. As of 2023, the market size was valued at approximately USD 214.36 million[3].

  • By 2030, the market is projected to reach nearly USD 301.63 million, growing at a CAGR of 5% from 2024 to 2030[3].
  • Another forecast indicates that the market could reach USD 267.60 million by 2030, with a CAGR of 4.7% during the period 2022-2030[4].
  • The L-carnitine supplements market specifically is expected to surpass USD 386 million by 2033, with a CAGR of 6% from 2023 to 2033[5].

Market Segmentation

The levocarnitine market is segmented based on product type, application, and region.

Product Type

  • The market is segmented into supplements, pharmaceuticals, and other categories. Supplements are a significant segment, driven by consumer demand for health and fitness products[1][3][5].

Application

  • Key applications include kidney health, bone health, brain health, weight management products, and others. The healthcare products segment, including supplements and nutraceuticals, is a major contributor to the market[1][4].

Regional Outlook

  • North America is the largest market shareholder, driven by high regional GDP, high per capita income, and increased healthcare awareness. Europe is expected to be the fastest-growing region[4].
  • Other significant regions include Asia-Pacific, Latin America, and the Middle East & Africa[1][2][4].

Market Drivers

Several factors are driving the growth of the levocarnitine market:

  • Rising Consumer Awareness: Increasing awareness of health and fitness among consumers is leading to higher demand for dietary supplements, including L-carnitine[2][5].
  • Health Benefits: L-carnitine is recognized for its role in energy metabolism, exercise performance, and its potential benefits in managing various health conditions such as type 2 diabetes, dyslipidemia, and heart diseases[4][5].
  • Animal Nutrition: The use of L-carnitine in animal feed is also a significant driver, particularly in the production of healthy animal food products[4].

Market Restraints

Despite the growth potential, there are some restraints to consider:

  • Regulatory Challenges: Strict regulatory environments in various regions can hinder the market growth. Ensuring compliance with health and safety standards is crucial[1][4].
  • Raw Material Costs: Fluctuations in the cost of raw materials can impact the production costs and profitability of L-carnitine manufacturers[5].

Competitive Landscape

The levocarnitine market is competitive, with several key players:

  • Major Players: Companies like AbbVie Inc. are significant players in the pharmaceutical industry, contributing to the market's growth in North America[4].
  • Research and Development: Continuous R&D activities by market participants are driving innovation and increasing market share[5].

Price Projections

The price projections for levocarnitine are closely tied to the market size and growth rates:

  • Current Market Size: As of 2023, the market size was valued at approximately USD 214.36 million[3].
  • Forecasted Market Size: By 2030, the market is expected to reach nearly USD 301.63 million[3], and by 2033, the L-carnitine supplements market is projected to surpass USD 386 million[5].

Regional Price Trends

  • North America: This region is expected to maintain its position as the largest market shareholder, with a CAGR of 5.3% during the forecast period[4].
  • Europe: Europe is anticipated to be the fastest-growing region, driven by increasing health awareness and the adoption of new ingredients in healthcare products[4].

Key Takeaways

  • The levocarnitine market is expected to grow significantly, driven by consumer health awareness and diverse applications.
  • North America is the largest market, with Europe being the fastest-growing region.
  • The market is segmented into supplements, pharmaceuticals, and other categories, with healthcare products being a major contributor.
  • Regulatory challenges and raw material costs are key restraints.
  • Continuous R&D activities are driving market growth and innovation.

FAQs

What is the projected market size of the levocarnitine market by 2030?

The levocarnitine market is expected to reach nearly USD 301.63 million by 2030, growing at a CAGR of 5% from 2024 to 2030[3].

What are the main drivers of the levocarnitine market?

The main drivers include rising consumer awareness of health and fitness, the role of L-carnitine in energy metabolism and exercise performance, and its use in animal nutrition[2][4][5].

Which region is expected to be the fastest-growing in the levocarnitine market?

Europe is anticipated to be the fastest-growing region, driven by increasing health awareness and the adoption of new ingredients in healthcare products[4].

What are the key applications of levocarnitine?

Key applications include kidney health, bone health, brain health, weight management products, and others, with a significant focus on healthcare products and supplements[1][4].

Who are the major players in the levocarnitine market?

Companies like AbbVie Inc. are significant players in the pharmaceutical industry, contributing to the market's growth in North America[4].

What are the restraints affecting the levocarnitine market?

Regulatory challenges and fluctuations in raw material costs are key restraints affecting the market growth[1][4][5].

Sources

  1. The Insight Partners, "Levocarnitine Market Dynamics 2021-2031"
  2. Polaris Market Research, "L-Carnitine Market Projection $339.54 Million By 2032 CAGR: 5.3%"
  3. Maximize Market Research, "L-Carnitine Market Global Industry Analysis and Forecast (2024-30)"
  4. Straits Research, "L-Carnitine Market Size, Share & Trends Analysis Report 2030"
  5. Future Market Insights, "L-carnitine Supplements Market Growth, Forecast to 2033"

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.